Clinical heterogeneity of ATP13A2 linked disease (Kufor-Rakeb) justifies a PARK designation
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
In this issue of Neurology , Di Fonzo and colleagues describe the identification of a Brazilian patient with juvenile parkinsonism who carries a homozygous missense mutation in ATP13A2 .1 Mutation of this gene has been recently shown to underlie the autosomal recessive, l-dopa–responsive, pallido-pyramidal disease Kufor-Rakeb syndrome (KRS). KRS was originally described by Al Din and colleagues in 1994, when they reported the clinical and radiologic features of five siblings born of a consanguineous marriage and living with their parents in the small homestead of Kufor-Rakeb in Jordan.2 Onset occurred between the ages of 12 and 15 years with lethargy and bradyphrenia evolving over several months culminating in social withdrawal and removal from schooling. Difficulties with walking due to stiffness and postural abnormalities started at around the same time. Within 2 years of onset problems with swallowing and articulating had appeared and assistance was required in several everyday tasks. Cognitive decline continued with slowness of thinking, perseveration, and utilization behavior …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews
Aharon-Peretz, J., Rosenbaum, H., & Gershoni-Baruch, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033277 · Cited by 597
Cited by
Gitler, A. D., Chesi, A., Geddie, M. L., Strathearn, K. E., Hamamichi, S., Hill, K. J., Caldwell, K. A., Caldwell, G. A., Cooper, A. A., Rochet, J.-C., et al. (2009) · Nature Genetics · doi:10.1038/ng.300 · Cited by 535
Lysosomal impairment in Parkinson's disease
Dehay, B., Martinez‐Vicente, M., Caldwell, G. A., Caldwell, K. A., Yue, Z., Cookson, M. R., Klein, C., Vila, M., & Bezard, E. (2013) · Movement Disorders · doi:10.1002/mds.25462 · Cited by 340
Paisán‐Ruiz, C., Guevara, R., Federoff, M., Hanagasi, H., Sina, F., Elahi, E., Schneider, S. A., Schwingenschuh, P., Bajaj, N., Emre, M., et al. (2010) · Movement Disorders · doi:10.1002/mds.23221 · Cited by 256
Self-citationGenetics of neurodegeneration with brain iron accumulation
Gregory, A., & Hayflick, S. J. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0181-3 · Cited by 104
Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration
Peng, W., Minakaki, G., Nguyen, M., & Krainc, D. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00742-3 · Cited by 79
Metadata
- Authors
- Lees, A. J., & Singleton, A. B.
- Venue
- Neurology
- Published
- 2007-05-08
- Volume
- 68
- Issue
- 19
- Pages
- 1553-1554
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2075478818
- Cited by
- 35
- References
- 2
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical heterogeneity of ATP13A2 linked disease (Kufor-Rakeb) justifies a PARK designation. https://app.cochat.ai/papers/10.1212/01.wnl.0000265228.66664.f4
- The paper
- Lees, A. J., & Singleton, A. B. (2007). Clinical heterogeneity of ATP13A2 linked disease (Kufor-Rakeb) justifies a PARK designation. Neurology. https://doi.org/10.1212/01.wnl.0000265228.66664.f4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.